Skip to main content
Premium Trial:

Request an Annual Quote

J&J Vaccine Benefits Outweighs Risk, EMA Says

The European Medicines Agency says that though the Johnson & Johnson SARS-CoV-2 vaccine may be associated with rare blood clot side effects, its benefits outweigh its risks, CNBC reports.

Earlier this month, officials in the US recommended pausing the use of J&J's vaccine while reports of rare, but serious blood clots combined with low blood platelet levels after receiving the vaccine were investigated. European officials likewise announced they would be looking into the reports.

In a press release, EMA recommends that a warning about the possibility of blood clots be added to the product information and said that the benefits of the vaccine in preventing COVID-19 outweigh the risk. "COVID-19 is associated with a risk of hospitalization and death," the agency says. "The reported combination of blood clots and low blood platelets is very rare."

As CNBC notes, EMA also recently reviewed cases of blood clots following vaccination with the SARS-CoV-2 vaccine from AstraZeneca and Oxford University and similarly concluded that the vaccine was safe.

According to Deutsche Welle, the US is expected to announce its decision on the J&J vaccine Friday.

The Scan

Genetic Ancestry of South America's Indigenous Mapuche Traced

Researchers in Current Biology analyzed genome-wide data from more than five dozen Mapuche individuals to better understand their genetic history.

Study Finds Variants Linked to Diverticular Disease, Presents Polygenic Score

A new study in Cell Genomics reports on more than 150 genetic variants associated with risk of diverticular disease.

Mild, Severe Psoriasis Marked by Different Molecular Features, Spatial Transcriptomic Analysis Finds

A spatial transcriptomics paper in Science Immunology finds differences in cell and signaling pathway activity between mild and severe psoriasis.

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.